3581 - 3590 of 7939 Results
Title
Year
- Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)2020OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 4
- Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM202020OPENTitle: Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00139-6Best OA location URL: https://www.nature.com/articles/s41531-020-00139-6.pdfCitation Count: 21
- Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysis2020OPENTitle: Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysisJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 4331End Page: 4343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-020-00967-1Best OA location URL: https://pure.rug.nl/ws/files/203826418/s41380_020_00967_1.pdfCitation Count: 65
- Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease2020OPENTitle: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 5Start Page: 831End Page: 846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12240Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12240Citation Count: 15
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 38
- A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes2020RESTRICTEDTitle: A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 2Start Page: 169End Page: 177Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1855145Citation Count: 9
- Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?2020RESTRICTEDTitle: Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?Journal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 44Issue #: 2Start Page: 301End Page: 311Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jimd.12326Citation Count: 2
-
OPENTitle: The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)Journal Name: ChemMedChemPublisher: WileyVol: 16Issue #: 6Start Page: 959End Page: 965Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cmdc.202000872Best OA location URL: https://doi.org/10.1002/cmdc.202000872Citation Count: 29
-
OPENTitle: Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor ComplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 1Start Page: 76End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13117Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13117Citation Count: 13
- Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders2020OPENTitle: Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disordersJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000924Best OA location URL: https://nn.neurology.org/content/nnn/8/1/e924.full.pdfCitation Count: 76